-

COPD Study Shows: Using the Kaia Health App, Positive Effects of Inpatient Rehabilitation Are Maintained Longer

NEW YORK--(BUSINESS WIRE)--In a study including patients with COPD, a chronic respiratory disease, physicians from Zurich Rehabilitation Centers and the University of Marburg examined how the use of Kaia Health affects physical activity after inpatient treatment. As a result, researchers found that with Kaia Health, improvements from inpatient rehabilitation were maintained over the entire study period of six months - compared to the control group. The study by Prof. Dr. A. Rembert Koczulla, Dr. Marc Spielmans et al. is the first scientific study that deals with the effects of digital therapeutics on pulmonary rehabilitation.

The Kaia Health COPD app provides key elements of pulmonary rehabilitation in digital form: an individual training program with movement units, breathing and relaxation exercises, as well as tips and information about the disease, guided by digital motion analysis. It can be used on its own as a digital therapeutic, or after inpatient therapy.

In the randomized controlled study, patients with COPD were observed over a period of six months after the end of their inpatient rehabilitation. The participants were randomly assigned to either the Kaia Health COPD app or conventional follow-up treatment. The research focus of the study was to measure physical activity – a crucial factor in rehabilitation. For this purpose, the steps taken by the participants each day were recorded by an activity tracker and then evaluated by the authors of the study.

“The results show significantly higher physical activity over a period of six months by using the Kaia Health COPD app compared to the control group. The Kaia Health COPD app has been proven to be an innovative way of positively influencing the health status of COPD patients over a longer period of time. Our next goal is to demonstrate the effectiveness in patients with COPD without previous treatment in rehabilitation as part of an ongoing follow-up study,” explains Stephan Huber, one of the co-authors of the study and Chief Medical Officer Europe at Kaia Health.

Improving symptoms with the Kaia Health COPD app

In addition to these findings, another figure particularly stands out from the study results: the CAT score. CAT stands for COPD Assessment Test (an assessment survey for COPD patients). Here, patients rate their symptoms – such as coughing, congestion or tightness in the chest – on a scale of 0-5 [1]. As part of the study on the effectiveness of the Kaia Health COPD app, the evaluation of study participants' CAT survey shows that the use of Kaia Health significantly reduces the general severity of symptoms. "Of course, we were very pleased with these positive study results, but were not surprised," says Prof. Koczulla, consultant pulmonologist at Kaia Health and co-author of the study. "With Kaia Health, the success of the inpatient rehabilitation over six months was maintained to the greatest extent during the study. Even slight improvements with symptoms can be achieved.”

When using Kaia Health, patients with COPD are no longer on their own after inpatient rehabilitation. This is particularly important because many of the millions of people affected by COPD in the United States find it difficult to return to everyday life after returning from rehabilitation and implement everything they have learned independently in four to six weeks of seminars and therapy [2]. With Kaia Health’s COPD app they have a reliable, digital companion at their side.

“Kaia Health was founded around a steadfast commitment to democratize healthcare for all,” says Kaia Health President, Nigel Ohrenstein. “Building off the demonstrable success of our digital MSK solution, we are excited about the potential the Kaia Health COPD app can bring to the U.S., which adds another layer of support to our mission to make clinically validated, cost effective digital therapies accessible anytime, anywhere and for anyone.”

About Kaia Health

Kaia Health is a digital therapeutics company that creates accessible, evidence-based treatments for a range of conditions, including MSK pain and COPD. Kaia Health covers 60 million lives globally, and its clinically proven motion analysis capability is transforming and democratizing healthcare through technology that patients can access anytime, anywhere, with the camera of their smartphone or tablet. Kaia Health is the most clinically validated digital MSK provider, and its motion analysis technology is as accurate as physical therapists in suggesting exercise corrections, resulting in equitable care regardless of BMI, age, gender, or location. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and has offices in New York and Munich. Learn more at www.kaiahealth.com.

Footnotes:

[1] www.catestonline.org
[2] Spruit MA, Singh SJ, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. https://www.atsjournals.org/doi/full/10.1164/rccm.201309-1634ST

Contacts

Media contact:
Jessy Green
jessy.green@svmpr.com
(917) 689-9295

Kaia Health


Release Summary
In the randomized controlled study, patients with COPD were observed over a period of six months after the end of their inpatient rehabilitation.
Release Versions

Contacts

Media contact:
Jessy Green
jessy.green@svmpr.com
(917) 689-9295

Social Media Profiles
More News From Kaia Health

Top Healthcare Executives Join Kaia Health’s Newly Created Advisory Board

NEW YORK--(BUSINESS WIRE)--Kaia Health, the largest global digital therapeutics company on a mission to deliver the most effective digital therapies – anytime, anywhere, today announced the appointment of four industry leaders to its newly created Advisory Board. Each of these phenomenal individuals brings a wealth of healthcare and tech experience across different disciplines that will help Kaia on its next phase of rapid growth and expansion. "The caliber of talent and experience that now mak...

Kaia Health Recognized as the First Musculoskeletal Digital Therapy to Deliver Best-in-Class Cost Saving and Health Outcomes

NEW YORK--(BUSINESS WIRE)--Kaia Health, today announced that it is the first and (currently only) MSK digital therapy, and the second digital health company in history, to receive Program Validation, the Validation Institute’s highest level of validation. The validation recognizes Kaia Health’s rigorous, evidence-based digital therapy approach to treating musculoskeletal conditions that led to its best-in-class financial and health outcomes. Kaia’s members saw significant pain reduction (33% af...

Kaia Health Raises the Bar for Automated Mobility Assessments with Launch of 3D Computer-Vision MSK Solution

NEW YORK--(BUSINESS WIRE)--Kaia Health, the largest global digital therapeutics company on a mission to deliver the most effective digital therapies – anytime, anywhere, today announced the addition of 3D full body mobility assessments, raising the bar for the standard of care delivery with motion analysis technology. The technology creates a full 3D model of the body, removing the need for restrictive placement of the phone, and tracks the most important skeletal structures with an eye to what...
Back to Newsroom